Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of an Injectable Hydrogel for Histotripsy Ablation Toward Future Glioblastoma Therapy Applications

Annals of Biomedical Engineering(2024)10.1007/s10439-024-03601-1Source: DataRank Database

Development of an Injectable Hydrogel for Histotripsy Ablation Toward Future Glioblastoma Therapy Applications is a research paper published in Annals of Biomedical Engineering (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (27)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Junru Zhang,Jessica M. Gannon ORCID,Blake N. Johnson ORCID,Scott S. Verbridge ORCID,Eli Vlaisavljevich ORCID

Live enrichment

PubMed:39210157 PMC:PMC11561036

National Science Foundation

Grant: CBET-1652112

National Institutes of Health

Grant: R15-GM137298

Natural Sciences and Engineering Research Council of Canada

Grant: Postgraduate Doctoral Scholar Award

Philanthropic Educational Organization

Grant: Scholar Award

Virginia Polytechnic Institute and State University

Grant: Computational Tissue Engineering Fellowship

National Institutes of Health

Grant: 1R15GM137298-01

Targeted ROS releasing PEG-Fibrin composite adhesive-hydrogel to control matrix modulation as a wound healing and tissue engineering support

Natural Sciences and Engineering Research Council of Canada

Grant: unidentified

unidentified

hybridLicense: cc-by

publisherhttps://link.springer.com/content/pdf/10.1007/s10439-024-03601-1.pdf

publisherhttps://link.springer.com/article/10.1007/s10439-024-03601-1/fulltext.html

repositoryhttps://vtechworks.lib.vt.edu/bitstreams/72654b80-f1fc-4406-9e51-7b1bab8e437e/download

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11561036/pdf/10439_2024_Article_3601.pdf

Europe_PMChttps://europepmc.org/articles/PMC11561036

Fields of Study

01 natural sciences03 medical and health sciences0302 clinical medicine0103 physical sciences

MeSH Terms

Cell Line, TumorAnimalsSwineHumansGlioblastomaBrain NeoplasmsHydrogelsHigh-Intensity Focused Ultrasound Ablation

Keywords

Ultrasound ImagingFocused ultrasoundGlioblastoma Resection CavityHistotripsy TreatmentRed Blood Cell AblationThiol-michael Addition Injectable HydrogelBrain NeoplasmsSwineHydrogelsCell Line, TumorAnimalsHumansHigh-Intensity Focused Ultrasound AblationOriginal ArticleGlioblastoma

Sustainable Development Goals

SDG 3: 3. Good health

Development of an Injectable Hydrogel for Histotripsy Ablation Toward Future Glioblastoma Therapy Applications

FAIR Checklist

Authors (6)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)